Dermata Therapeutics announces up to $12.4 million private placement
Source: SeekingAlpha
2025-12-24 08:26:06 ET
More on Dermata Therapeutics
- Dermata Therapeutics GAAP EPS of -$1.65
- Seeking Alpha’s Quant Rating on Dermata Therapeutics
- Historical earnings data for Dermata Therapeutics
- Financial information for Dermata Therapeutics
Read the full article on Seeking Alpha
For further details see:
Dermata Therapeutics announces up to $12.4 million private placement
Dermata Therapeutics Inc. Warrant
NASDAQ: DRMAW
DRMAW Trading
0.0% G/L:
$0.0165 Last:
200 Volume:
$0.0165 Open:
DRMAW Latest News
March 10, 2026 08:30:00 am
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing
January 20, 2026 08:05:00 am
Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office
December 29, 2025 04:05:00 pm
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
DRMAW Stock Data
$4,786,231
2,386,624
10%
6
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
